146 related articles for article (PubMed ID: 36777519)
1. Targeted delivery of Dbait by an artificial extracellular vesicle for improved radiotherapy sensitivity of esophageal cancer.
Chen M; Wang Y; Lin J; Galstyan L; Qiao J; Ghazaryan A; Li B; Li H
Am J Cancer Res; 2023; 13(1):105-117. PubMed ID: 36777519
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle formulation of small DNA molecules, Dbait, improves the sensitivity of hormone-independent prostate cancer to radiotherapy.
Yao H; Qiu H; Shao Z; Wang G; Wang J; Yao Y; Xin Y; Zhou M; Wang AZ; Zhang L
Nanomedicine; 2016 Nov; 12(8):2261-2271. PubMed ID: 27389144
[TBL] [Abstract][Full Text] [Related]
3. Development of a Hypoxic Radiosensitizer-Prodrug Liposome Delivery DNA Repair Inhibitor Dbait Combination with Radiotherapy for Glioma Therapy.
Liu H; Cai Y; Zhang Y; Xie Y; Qiu H; Hua L; Liu X; Li Y; Lu J; Zhang L; Yu R
Adv Healthc Mater; 2017 Jun; 6(12):. PubMed ID: 28371526
[TBL] [Abstract][Full Text] [Related]
4. A preclinical study combining the DNA repair inhibitor Dbait with radiotherapy for the treatment of melanoma.
Biau J; Devun F; Jdey W; Kotula E; Quanz M; Chautard E; Sayarath M; Sun JS; Verrelle P; Dutreix M
Neoplasia; 2014 Oct; 16(10):835-44. PubMed ID: 25379020
[TBL] [Abstract][Full Text] [Related]
5. Combining the DNA Repair Inhibitor Dbait With Radiotherapy for the Treatment of High Grade Glioma: Efficacy and Protein Biomarkers of Resistance in Preclinical Models.
Biau J; Chautard E; Berthault N; de Koning L; Court F; Pereira B; Verrelle P; Dutreix M
Front Oncol; 2019; 9():549. PubMed ID: 31275862
[TBL] [Abstract][Full Text] [Related]
6. [Dbait: An innovative concept to inhibit DNA repair and treat cancer].
Biau J; Devun F; Verrelle P; Dutreix M
Bull Cancer; 2016 Mar; 103(3):227-35. PubMed ID: 26917468
[TBL] [Abstract][Full Text] [Related]
7. Improving radio-chemotherapy efficacy of prostate cancer by co-deliverying docetaxel and dbait with biodegradable nanoparticles.
Liu N; Ji J; Qiu H; Shao Z; Wen X; Chen A; Yao S; Zhang X; Yao H; Zhang L
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):305-314. PubMed ID: 31858836
[TBL] [Abstract][Full Text] [Related]
8. Preclinical study of the DNA repair inhibitor Dbait in combination with chemotherapy in colorectal cancer.
Devun F; Bousquet G; Biau J; Herbette A; Roulin C; Berger F; Sun JS; Robine S; Dutreix M
J Gastroenterol; 2012 Mar; 47(3):266-75. PubMed ID: 22068457
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of a PROTAC induced PDEδ degrader by a biomimetic drug delivery system for enhanced cytotoxicity against pancreatic cancer cells.
Fan R; He S; Wang Y; Qiao J; Liu H; Galstyan L; Ghazaryan A; Cai H; Feng S; Ni P; Dong G; Li H
Am J Cancer Res; 2022; 12(3):1027-1041. PubMed ID: 35411249
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy.
Quanz M; Berthault N; Roulin C; Roy M; Herbette A; Agrario C; Alberti C; Josserand V; Coll JL; Sastre-Garau X; Cosset JM; Larue L; Sun JS; Dutreix M
Clin Cancer Res; 2009 Feb; 15(4):1308-16. PubMed ID: 19190126
[TBL] [Abstract][Full Text] [Related]
11. Distribution and radiosensitizing effect of cholesterol-coupled Dbait molecule in rat model of glioblastoma.
Coquery N; Pannetier N; Farion R; Herbette A; Azurmendi L; Clarencon D; Bauge S; Josserand V; Rome C; Coll JL; Sun JS; Barbier EL; Dutreix M; Remy CC
PLoS One; 2012; 7(7):e40567. PubMed ID: 22815765
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer metastasis: the DNA repair inhibitor Dbait increases sensitivity to hyperthermia and improves efficacy of radiofrequency ablation.
Devun F; Biau J; Huerre M; Croset A; Sun JS; Denys A; Dutreix M
Radiology; 2014 Mar; 270(3):736-46. PubMed ID: 24475822
[TBL] [Abstract][Full Text] [Related]
13. A tumor microenvironment-responsive micelle co-delivered radiosensitizer Dbait and doxorubicin for the collaborative chemo-radiotherapy of glioblastoma.
Zhang S; Jiao X; Heger M; Gao S; He M; Xu N; Zhang J; Zhang M; Yu Y; Ding B; Ding X
Drug Deliv; 2022 Aug; 29(1):2658-2670. PubMed ID: 35975300
[TBL] [Abstract][Full Text] [Related]
14. Dual-targeting and microenvironment-responsive micelles as a gene delivery system to improve the sensitivity of glioma to radiotherapy.
Jiao X; Yu Y; Meng J; He M; Zhang CJ; Geng W; Ding B; Wang Z; Ding X
Acta Pharm Sin B; 2019 Mar; 9(2):381-396. PubMed ID: 30972284
[TBL] [Abstract][Full Text] [Related]
15. Integrated radiochemotherapy study of ZIF-8 coated with osteosarcoma-platelet hybrid membranes for the delivery of Dbait and Adriamycin.
Du L; Zhu G; Xu Y; Han B; Wang Y; Zhu M; Meng Y; Chen H; Yu Z
Front Bioeng Biotechnol; 2023; 11():1147064. PubMed ID: 36873373
[No Abstract] [Full Text] [Related]
16. Hyperactivation of DNA-PK by double-strand break mimicking molecules disorganizes DNA damage response.
Quanz M; Chassoux D; Berthault N; Agrario C; Sun JS; Dutreix M
PLoS One; 2009 Jul; 4(7):e6298. PubMed ID: 19621083
[TBL] [Abstract][Full Text] [Related]
17. Comparison of distribution and activity of nanoparticles with short interfering DNA (Dbait) in various living systems.
Berthault N; Maury B; Agrario C; Herbette A; Sun JS; Peyrieras N; Dutreix M
Cancer Gene Ther; 2011 Oct; 18(10):695-706. PubMed ID: 21799529
[TBL] [Abstract][Full Text] [Related]
18. The DNA Repair Inhibitor Dbait Is Specific for Malignant Hematologic Cells in Blood.
Thierry S; Jdey W; Alculumbre S; Soumelis V; Noguiez-Hellin P; Dutreix M
Mol Cancer Ther; 2017 Dec; 16(12):2817-2827. PubMed ID: 28947503
[TBL] [Abstract][Full Text] [Related]
19. Angiopep-2 Modified Cationic Lipid-Poly-Lactic-Co-Glycolic Acid Delivery Temozolomide and DNA Repair Inhibitor Dbait to Achieve Synergetic Chemo-Radiotherapy Against Glioma.
Li S; Xu Q; Zhao L; Ye C; Hua L; Liang J; Yu R; Liu H
J Nanosci Nanotechnol; 2019 Dec; 19(12):7539-7545. PubMed ID: 31196258
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept.
Solass W; Herbette A; Schwarz T; Hetzel A; Sun JS; Dutreix M; Reymond MA
Surg Endosc; 2012 Mar; 26(3):847-52. PubMed ID: 22042585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
